Fluconazole‐Induced Fixed Drug Eruption With Cross‐Reactivity to Clotrimazole—Confirmation With Patch Testing [PDF]
First described in 1994, fixed drug eruption (FDE) to fluconazole is uncommon but possibly underdiagnosed. Of these, women with vaginal candidiasis remain the most affected, with on average more than four occurrences prior to diagnosis. We present a case of a 29‐year‐old female who presented after her third episode of an itchy, oedematous, blistering ...
Sron D +4 more
europepmc +2 more sources
Ibrexafungerp: Mechanism of Action, Clinical, and Translational Science. [PDF]
ABSTRACT Ibrexafungerp is a first‐in‐class triterpenoid antifungal that targets β‐(1,3)‐glucan synthase in fungal cell wall development. It is indicated for vulvovaginal candidiasis (VVC) and recurrent vulvovaginal candidiasis (RVVC) in adult and post‐menarchal pediatric females.
Walley AH +3 more
europepmc +2 more sources
Non-albicans Candida in Vulvovaginal Candidiasis: Antifungal Resistance and Expression of ERG11, CDR1, CDR2, and MDR1 Genes. [PDF]
The rise in azole resistance among Nakaseomyces glabratus and Pichia kudriavzevii presents a growing public health challenge. These results indicate that even in cases where an isolate is classified as susceptible by drug susceptibility testing, elevated gene expression may persist, and treatment should not be discontinued.
Ranjbar Golafshani FZ +3 more
europepmc +2 more sources
Frequency and Etiology of Vulvovaginal Candidiasis in Women Referred to a Gynecological Center in Babol, lran [PDF]
Background Vulvovaginal candidiasis is the most common fungal disease in sexually active women of which Candida albicans is the primary etiologic agent. Materials and methods This cross-sectional study was performed to determine the etiologic agents of
Seddigheh Esmaeilzadeh +2 more
doaj +1 more source
Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented. [PDF]
BACKGROUND: Available literature concerning the epidemiologic or clinical features of vulvovaginal candidiasis commonly reports that: 75% of women will experience an episode of vulvovaginal candidiasis in their lifetimes, 50% of whom will experience at ...
Buffler, Patricia A, Rathod, Sujit D
core +1 more source
Vulvovaginal Candidiasis in Pregnant Women and its Importance for Candida Colonization of Newborns
Vulvovaginal candidiasis is the second most common cause of vaginitis worldwide (after bacterial candidiasis). Maternal vulvovaginal candidiasis is a major risk factor for Candida colonization and infection of the infant where prognosis depends on ...
Zisova Liliya G. +8 more
doaj +1 more source
Epidemiological data on women suffering from vulvovaginal candidiasis and its recurrence are outdated and vague. The aim of this study was to identify the prevalence of women diagnosed with vulvovaginal candidiasis, as well as the epidemiological profile
Encarnación Martínez-García +6 more
doaj +1 more source
Aim - to determine population levels of main microbiota and yeast-like fungi of the genus Candida in healthy women and in women with vulvovaginal candidiasis. Materials and methods. For 10 years we have been surveyed 270 women in reproductive age from
N. D. Yakovychuk +5 more
doaj +1 more source
Attending to Gyn-Ecology: Managing the 'Mess' of Recurrent Vulvovaginal Thrush. [PDF]
ABSTRACT Previous social science research on gendered experiences of thrush and vulvovaginal health has overlooked, or inadvertently sanitised, the materiality of having a body. Therefore, this study aims to return attention to the material, sensorial, and corporeal dimensions of living with recurrent thrush and use this to broaden our understandings ...
Ford T +4 more
europepmc +2 more sources
Nucleic acids enrichment of fungal pathogens to study host-pathogen interactions [PDF]
Fungal infections, ranging from superficial to life-threatening infections, represent a major public health problem that affects 25% of the worldwide population.
Coucke, Paul +3 more
core +1 more source

